DEBORAH FRENCH: Open Payments
NPI 1952373854 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 95 payments from 21 companies in 2025. Trend: 2023 $1,390 · 2024 $1,771 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $260 |
| ABBVIE INC. | 20 | $228 |
| AstraZeneca Pharmaceuticals LP | 9 | $189 |
| Eisai Inc. | 4 | $110 |
| Axsome Therapeutics, Inc. | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| Lilly USA, LLC | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 7 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
Products named: Wegovy, Leqembi, JARDIANCE, FARXIGA, Auvelity, QULIPTA, VOQUEZNA, Ozempic.
Industry payments across KY — which companies pay providers there.
